Effectiveness of Smartphone Devices in Promoting Physical Activity and Exercise in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review. by Rabinovich, Roberto A. et al.
ICOP_A_1358257 TFJATS_ComSerif-800.cls(800C) August 11, 2017 21:30 Trim Info: 8.25in× 11in
ICOP #1358257, VOL 0, ISS 0
Eﬀectiveness of Smartphone Devices in Promoting Physical Activity and Exercise in
Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review
María del M. Martínez-García, Juan D. Ruiz-Cárdenas, and Roberto A. Rabinovich
QUERY SHEET
This page lists questions we have about your paper. The numbers displayed at left can be found in the text of the paper for reference.
In addition, please review your paper as a whole for correctness.
Q1. Au: Please advise if the term ‘attain’ should be changed to ‘obtain’ in the text ‘To attain additional eligible articles’ for readability.
Q2. Au: Please advise if the edits for language made throughout the article, including the sentence ‘The role of smartphones in
increasing PA level (steps’, retain the intended meaning.
Q3. Au: Please advise if the term ‘taken’ should be changed to ‘interpreted’ in the text ‘data should be taken with caution’ and in
subsequent occurrences for readability.
Q4. Au: Please check the text ‘is yet too soon to be shown’ for clarity.
Q5. Au: Please check the usage of the word ‘pillars’ in the text ‘The promotion of physical activity (PA) is one of the fundamental
pillars in the management’ for correctness.
Q6. Au: Please rephrase the text ‘and a decreased of 13%’ for clarity.
Q7. Au: Please rephrase the sentence ‘This issue together with the spacing of the buttons and …’ as it exceeds the maximum word
limit.
Q8. Au: Please rephrase the text ‘an increase research field’ for clarity.
TABLE OF CONTENTS LISTING
The table of contents for the journal will list your paper exactly as it appears below:
Effectiveness of Smartphone Devices in Promoting Physical Activity and Exercise in Patients with Chronic Obstructive
Pulmonary Disease: A Systematic Review
María del M. Martínez-García, Juan D. Ruiz-Cárdenas, and Roberto A. Rabinovich
ICOP_A_1358257 TFJATS_ComSerif-800.cls(800C) August 11, 2017 21:30 Trim Info: 8.25in× 11in
COPD: JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
, VOL. , NO. , –
https://doi.org/./..
Eﬀectiveness of Smartphone Devices in Promoting Physical Activity and Exercise in
Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review
María del M. Martínez-García a,b, Juan D. Ruiz-Cárdenas c, and Roberto A. Rabinovich d
aCystic Fibrosis Association of Murcia, Murcia, Spain; bCardiovascular and Respiratory Physiotherapy Research Group (GIFISCAR), Faculty of Health
Sciences, Catholic University of Murcia, Murcia, Spain; cGI. ECOFISTEM, Faculty of Health Sciences, Catholic University of Murcia, Murcia, Spain;
dELEGI Colt Laboratory, Centre for Inﬂammation Research, The Queen’s Medical Research Institute, University of Edinburgh, Scotland, UK
ARTICLE HISTORY
KEYWORDS
Cell phones; exercise
therapy; lung diseases;
physical ﬁtness
ABSTRACT
The objectives of this systematic review were to analyse existing evidence on the efficacy of smartphone
devices in promoting physical activity (PA) in patients with chronic obstructive pulmonary disease (COPD)
and to identify the validity and precision of their measurements. A systematic review was undertaken
across nine electronic databases: WOS Core Collection, PubMed, CINAHL, AMED, Academic Search
Complete, Cochrane Central Register of Controlled Trials, SciELO, LILACS and ScienceDirect. Randomized
and non-randomized controlled clinical trials were identified. To attain additional eligible articles, the
reference lists of the selected studies were also checked. Eligibility criteria and risk of bias were assessedQ1
by two independent authors. A total of eight articles met eligibility criteria. The studies were focused on
promoting PA (n = 5) and the precision of device measurements (n= 3). The effectiveness of smartphones
in increasing PA level (steps/day) at short and long term is very limited. Mobile-based exercise programsQ2
reported improvements in exercise capacity (i.e. incremental Shuttle-Walk-Test) at short and long term
(18.3% and 21%, respectively). The precision of device measurements was good-to-excellent (r= 0.69–0.99);
however, these data should be taken with caution due to methodological limitations of studies. TheQ3
effectiveness of smartphone devices in promoting PA levels in patients with COPD is yet too soon to be
shown. Further high-quality studies are needed to evaluate the effectiveness of smartphone devices inQ4
promoting PA levels. Registration number: CRD42016050048.
Introduction
The promotion of physical activity (PA) is one of the funda-
mental pillars in the management of patients with chronic
obstructive pulmonary diseases (COPD). Reduced levels of PAQ5
in patients with COPD have been associated with a higher rate5
of disease progression, increased rates of hospital admissions
and mortality (1, 2). Interventions facilitating follow-up assess-
ment and self-monitoring of PA levels using pedometers have
been recommended to promote behavioural changes to avoid
PA decline (3). A systematic review of randomized controlled10
trials on PA self-monitoring using pedometers reported an
increase in steps per day of 27% over baseline and an average
of 2,500 steps more than the control group, highlighting these
devices as a useful tool to improve PA levels in patients with
COPD (4).15
Advances in hand-held technology offers potential to
integrate these devices into smartphone applications (App),
allowing health care personnel and researchers to objectively
monitor activity levels in real-time (e.g. intensity, frequency and
duration) and to promote an active life style. With this objective20
control, the evolution of the patient’s treatment can be easily
monitored and modified individually, thus avoiding demoti-
vation which can lead to the abandonment of the practice of
CONTACT María del Mar Martínez-García mariadelmarmargar@gmail.com Faculty of Health Sciences, Catholic University of Murcia, Jeronimos avenue , 
Murcia, Spain.
PA and, therefore, to treatment failure. In this new approach,
several systematic reviews (5, 6) have reported improvements 25
in PA levels through the use of smartphone devices among dif-
ferent populations. However, no previous study has completed
an exhaustive review of the role of these devices in promoting
PA levels in patients with COPD.
The objectives of this systematic review were (i) to analyse 30
existing evidence on the efficacy of smartphone devices in pro-
moting PA in patients withCOPDand (ii) to identify the validity
and precision of their measurements.
Material andmethod
Design 35
This systematic review was designed according to the Preferred
Reporting Items for Systematic reviews and Meta-Analyses (7)
guidelines and was registered in the international database of
systematic reviews PROSPERO: CRD42016050048.
In order to ensure that no similar systematic review had been 40
carried out previously, the Cochrane Library and the Interna-
tional Registry of Systematic Reviews Database (PROSPERO)
were consulted.
©  Taylor & Francis Group, LLC
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Search strategy and information sources
A bibliographic search was performed in the WOS Core Col-45
lection, PubMed, CINAHL, AMED, Academic Search Complete,
Cochrane Central Register of Controlled Trials (CENTRAL),
SciELO, LILACS and ScienceDirect computerized databases.
The last search was performed on May 14, 2017.
The terms included in the search strategy were: mobile50
phone, smartphone, cell phone, physical activity, fitness, exercise,
training, intervention, pulmonary disease, validity, precision, reli-
ability. Finally, the reference lists of the included studies were
manually searched. In order to obtain additional articles, the
reference lists of the included studies were reviewed. For more55
details on the search strategies used, please refer to protocol (8).
Eligibility criteria
The revised articles had to be published in international peer
review journals or as full-text entries in international scientific
conferences. These studies had to focus on the promotion or60
validity of smartphone devices to record PA levels in patients
with COPD. Those studies that showed results as a whole with-
out any discernment between patients with COPD and those
with other diseaseswere excluded. Two reviewers independently
selected the articles after reading the full text. Disagreements65
were resolved by consensus between the two reviewers.
Data extraction
The PICOS (7) strategy was used for the extraction of data.
This strategy takes into account the participants’ characteristics,
the type of intervention, the characteristics of the comparison70
group, the results reported and the study’s design. In addition,
data on the origin of the study (authors, year, population and
objectives) were also extracted.
From the articles that tested the precision of the device, the
data on smartphone placement, sampling frequency, software75
and data precision were extracted.
Risk of bias assessment
The risk of bias assessment included an adequate sequence
generation, concealment of allocation sequence, blindness of
evaluators, use of intention-to-treat analysis, and description80
of losses and exclusions. Studies without clear descriptions of
an adequate sequence generation or how the allocation list was
concealed were considered not to have fulfilled these criteria.
The evaluation was performed independently by two reviewers
and disagreements were resolved by consensus between the two.85
Results
Identification and selection process
A total of 89 articles were identified in the computerized
databases. Additionally, 1 potentially eligible article was
retrieved after analysing the reference lists of those identi-90
fied through the search strategy (Figure 1). After eliminating
duplicates, 51 full-text articles were examined to assess their
eligibility. Out of these, 39 articles did not meet the established
inclusion criteria, while 4 articles were excluded because the
sample was composed by patients with COPD and patients with 95
type II diabetes and the results were not provided separately.
Finally, 8 articles were included in the qualitative synthesis of
this systematic review.
Characteristics of the studies and risk of bias
The selected articles focused on two different categories: those 100
who aimed to increase PA levels developing an active lifestyle
program through a smartphone device (n= 5) (9–13) and those
who observed the precision of the smartphone devices com-
pared to validated tri-axial accelerometers (n = 3) (14–16).
The design of the studies was non-randomized controlled 105
clinical trials (n= 3) (14–16) and randomized controlled clinical
trials (n = 5) (9–13) whose publication period ranged between
2008 (12) and October 2016 (11).
All studies had a high risk of bias in at least one field; 62.5%
of articles presented adequate sequence generation (5 of 8) 110
(9–13), no article reported on concealment of allocation
sequence and only one reported on blinded evaluators (11),
62.5% used intention-to-treat principle (5 of 8) (9, 10, 12, 13,
16) and 100% of the articles described losses to follow-up and
exclusions (8 of 8) (9–16). 115
Characteristics of the participants
The sample size of the studies included in the present review
was 374 participants aged between 18 and 89 years (9–16). All
participants were patients diagnosed with COPD (GOLD I, II
and III classification) (9–16). 120
Devices used by studies
Four of the eight studies used the tri-axial accelerometers inte-
grated into the smartphone devices to measure PA levels (11,
14–16) and two other studies used external tri-axial accelerom-
eters through which these parameters were recorded and sent 125
to the smartphone device through Bluetooth® connection (9,
10). Finally, two studies used the mobile device to control the
parameters of a walking training program through a music
player software integrated into the smartphone. The software
collected the time used at a previously fixed intensity without 130
the need to use an accelerometer (12, 13) (Table 1).
Active lifestyle programs
Only five studies among the eight included in this review
performed an active lifestyle program (9–13). The frequency
of the programs was 4–7 days a week (9–13) with a duration 135
between 4 weeks (9, 10) and 12 months (11, 12). Three stud-
ies provided real-time feedback of the PA level (number of
steps) through the smartphone device (9–11). Patients were
encouraged to achieve their personalized physical activity goal
viewing the smartphone screen and receiving motivational text 140
messages (9–11). The personalized physical activity goal was
adjusted to +20% of baseline measure (11) or fixed to 50%
of the physical activity level based on 56 healthy individuals
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Figure . Flow chart of the selection process of the studies.
(9, 10). Moreover, two studies (12, 13) designed an exercise
program using a music player integrated into the smartphone.145
The subjects were instructed to walk to the rhythm of the
music played by the mobile device which was previously set
to an equivalent intensity of 80% of the estimated V’O2max
through the incremental Shuttle Walk Test (ISWT). The inten-
sity was revaluated every 4 weeks during the first 3 months150
(12, 13). When patients pressed the smartphone’s music player,
the device software recorded the session time. The duration
of the training sessions lasted until they could not keep up.
Then the subject stopped the playback. The subjects in the
control group, consisting of patients with similar character- 155
istics, were verbally asked to perform daily walking at home
(Table 2).
Table . Devices used by the studies to control physical activity and exercise.
Author (year) Smartphone External device
Liu et al. () () Sony Ericsson Ki (Sony, Tokyo, Japan) No
Tabak et al. () () HTC P/ (HTC, New Taipei, Taiwan) Sensor MTX-W
(Xens Technology, Enschede, Holland)
Tabak et al. () () HTC P/ (HTC, New Taipei, Taiwan) Sensor MTX-W
(Xens Technology, Enschede, Holland)
Wang et al. () () n/m No
Juen et al. () () Motorola Droid Mini (Motorola, Illinois, USA)
Samsung Galaxy Ace (Samsung, Seoul, South Korea)
LG Optimus Zone (LG, Seoul, South Korea)
No
Juen et al. () () Samsung S (Samsung, Seoul, South Korea)
Samsung Galaxy Ace (Samsung, Seoul, South Korea)
Motorola Droid Mini (Motorola, Illinois, USA)
Samsung Galaxy Ace (Samsung, Seoul, South Korea)
LG Optimus Zone (LG, Seoul, South Korea)
No
Vorrink et al. () (, ) HTC Desire A (HTC, New Taipei, Taiwan) No
n/m, not mentioned.
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Overall, the included studies reported no significant changes
in PA level at the end of the intervention (9–11). Only one
study showed improvements in the time of walking, patients160
were able to improve up to 26.7% (35 minutes of walking) at
12 weeks compared to baseline but a plateau was reached during
the self-managed period (the following 9 months). Addition-
ally, Tabak et al. (10) reported a significant increase of 13%
(104 steps/minute) in steps per minute at short term (4 weeks)165
in the experimental group, but this increase was observed only
after reducing the baseline by 13.21% (−121.5 steps/minute) in
order to correct the reactivity effect caused by the smartphone,
i.e. the increase in PA level simply by wearing a pedometer
(17). The results in the control group were very similar and no170
differences were found between groups.
Improvements in exercise capacity were evaluated in three of
the included studies (11–13). The results showed improvements
of 18.3% (58.5 m) and 21% (68.4 m) compared to baseline
(walking distance during ISWT) at 6 and 12 months, respec-175
tively (12, 13) and a decreased of 13% (28.9 m) at 6 months
was observed in the control group (13). However, the study
Q6
with the longest intervention (12 months) and highest sample
size reported no differences between groups for any analysed
variable: steps per day, metabolic equivalent, 6-minute walk180
test performed on a 10-m course (18), dyspnoea, emotional
function, self-control and body mass index. Furthermore, both
groups decreased their levels of physical activity in a similar
way, indicating no interaction caused by the intervention (11).
Adherence to the use of the mobile device was very high185
89–100% (9, 11), interestingly 86% of patients used the mobile
device more days than prescribed (9). Adherence to the pro-
gram moderately correlated with changes in PA levels (9).
However, there were patient dropouts in all studies during the
follow-up process (9–11). Althoughmost of the participants left190
for personal and health-related problems, an elevated number
of participants (fifteen subjects) dropped out due to technical
problems or dissatisfaction with devices (9–12) while another
six were excluded because they were not sufficiently compliant
to the program (9, 10).195
Precision of smartphone devices
The precision of the smartphone devices (Motorola Droid Mini,
Samsung Galaxy Ace, LG Optimus Zone, Samsung S5, HTC
Desire A8181) was compared with validated tri-axial accelerom-
eters (Zephyr BioHarness, Actigraph GT3X, SenseWear PRO200
ArmBand) (14–16) and assessed through an 8-day recording of
everyday activities (14) or by walking ten laps in a ten-metre
hallway (15, 16). The devices were placed at L3 level (15, 16) or
on the right arm of the subject (14) recording at a sample fre-
quency of 10–60 Hz (14–16).205
The authors reported a very high precision of the smart-
phone devices. The analysis of variance (ANOVA) between
each of the signals from the smartphone and the gold standard
showed a probability of differences (F-test) below 1.114e-4 when
the smartphone was ported by one subject walking during ten210
laps in a ten-metre hallway (15, 16). Additionally, the reliabil-
ity between the smartphone device (HTCDesire A8181) and the
validated accelerometer (BHC0100 SenseWear PRO ArmBand)
when both were ported by 10 subjects during everyday activities
reported a range of r = 0.69–0.99 (Pearson’s correlation coeffi- 215
cient) (14). However, several missing data were reported due to
problems with the smartphone device (14) (Table 3).
Discussion
The interventions that facilitate self-monitoring of PA levels
have been recommended to improve behavioural changes 220
related to physical inactivity (3). The latest technical innova-
tions in smartphone devices provide additional tools for the
self-monitoring of PA levels (6) and the possibility of improving
health-related habits in patients with COPD. However, the
scientific evidence consulted does not highlight smartphone 225
devices as an effective tool to increase PA levels in patients
with COPD. The studies did not report differences in PA
levels when compared to the control group that performed
routine physiotherapy and medication care (9–11). This can
be due to several methodological aspects: (i) authors did not 230
blind participants to study aims during the first week of PA
baseline-measurement, (ii) subjects in the control group who
were carrying a pedometer were not blinded to the step count
display, (iii) the validity and precision of the data collected
through their smartphone devices was not verified (9–11), these 235
issues could lead to differences in their results.
Previous studies have observed changes in participants’ activ-
ity level (steps/day) by the simple way to wearing a pedometer
(17, 19), this phenomenon is called reactivity effect and could
be minimized when patients are blinded to the study aim or to 240
the step count display (19). Therefore, greater differences could
have been found if participants would have been blinded. In this
context, Tabak et al. (10) observed a decrease in the number of
steps/day in the control group after the second week of inter-
vention which could be explained by a return to baseline val- 245
ues caused by a previous reactivity effect. Thus, after adjusting
for the reactivity effect caused by the smartphone device, they
reported a 13% increase in PA levels in the experimental group
after 4 weeks of intervention.
Although several authors have shown increases in PA levels 250
after performing a short-term intervention (4–12 weeks) using
pedometers (20–22), long-term studies (12months) do not con-
firm these results (23–25). In a recent study byMoy et al. (24), an
increase in the number of steps/day was observed at 4 months
compared to the control group and a return to baseline levels 255
after 12 months of intervention. Liu et al. (12) showed improve-
ments in the time of walking after a mobile-home-based pro-
gram at 12 weeks; however, a plateau was reached during the
following 9 months. In the same way, Vorrink et al. (11) did not
report changes in PA levels during 12 months of intervention. 260
These results suggest that although small improvements can be
observed in short-term interventions, the results for long-term
interventions do not appear to be promising.
Although the reported adherence to wearing the smartphone
device was significantly high and there was association between 265
program adherence and improvements in PA level, a high rate of
data and participants were lost in all studies (9–13). An impor-
tant issue is the high loss rate (35.4%) caused by problems related
to the smartphone device: technical problems, missing data or
dissatisfactionwith devices (9–12). The development anddesign 270
of the smartphone application is a fundamental aspect in the
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adherence and subsequent treatment success. Elderly people
have difficulty in accurately pressing the buttons of the smart-
phone screen (26). This issue together with the spacing of the
buttons and the size of the devices (14)makes the need to design275
mobile applicationswith an interface that allows tominimize the
losses due to technical problem or discomfort which could be a
strategy to increase adherence and improve PA level in COPD
patients. A recent study of Bartlett et al. (27) reported differ-Q7
ences between three persuasive-App designs for encouraging PA280
in patients with COPD, authors informed about the importance
of selecting an adequate design approach for encouraging PA
levels supporting our previous idea.
The fact that no study aiming at promoting PA levels ver-
ified the validity and precision of their devices (9–11) might285
be biasing the results. Although the authors favour the use of
smartphone devices as a valid and precision tool for the objec-
tive control of PA in a clinical environment (14–16), in research
environments the evidence is still scarce. A recent systematic
review (6) indicated that smartphone devices had a precision290
of 52–100% when carried by a sample composed mostly of
overweight and healthy adults. However, these devices often
have a high error when used in chronic elderly patients mainly
due to their slow speed of walking, i.e. shuffling gait, which
sometimes leads to the underestimation of the number of steps295
(28). Although those studies focused on analysing the valid-
ity of these devices reported good to excellent precision in
patients with COPD and healthy subjects, these data should be
taken with caution due to the methodology used by the authors
(14–16). While the accelerometers Actigraph GT3X and300
SenseWear PRO ArmBand have been previously validated in
elderly and patients with COPD (29, 30), to our knowledge the
Zephyr BioHarness accelerometer used as gold standard in one
study (16) has not been previously validated in a sample with
these characteristics, therefore it could be an incorrect use as305
gold standard. Additionally, the statistical method used to cal-
culate the validity of the smartphone device is incomplete. The
ANOVA, used in two of the three studies (15, 16), is a method
that yields information only on the differences betweenmeans of
two sets of data but not on the individual differences of the data310
(31). Therefore, this test should not be used in isolation to assess
the smartphone validity (32). Similarly, Pearson’s correlation
coefficient used in the last study (14) yields information on the
degree of association between two sets of data, however, it does
not detect any systematic errors. In this way, it is possible to have315
two datasets that are highly correlated but not highly repeatable
(31, 32). Finally, the sample size of the studies assessing precision
between devices was very low (14–16). A concurrent-validity
study performed in only one subject in terms of methodological
design is incorrect mainly because the inter-individual variabil-320
ity is not considered. A device should be tested inmore than one
subject to report in terms of validity (31, 32). Thus, data concern
to the validity and reliability of smartphone devices for measur-
ing steps per day in patients with COPD is very poor and further
high-quality studies are necessary.325
Limitations
Despite a rigorous approach towards data collection and synthe-
sis, this review is not without limitations. Since publication bias
exists (small studies with negative effects are unpublished or less
accessible than larger studies) (33), the searches performed in 330
this systematic review may not have introduced the entire grey
literature on this topic, so the resultsmust be takenwith caution.
In any case, the inclusion of grey literature tends to attenuate the
effect. Additionally, two researchers assessed the risk of bias and
the study selection process. Because there were no discrepancies 335
between them, there was no need for a third opinion.
The promotion of PA through smartphone devices consti-
tutes an increase research field. Only eight studies were included Q8
in this systematic review, not all studies used validated smart-
phone devices and most interventions were performed at short 340
term which could be influencing their results. There is lit-
tle evidence and its low methodological quality hinders any
robust conclusions about its effectiveness. The present review
has observed methodological issues which further studies can
use to improve their designs and to clarify the effects of smart- 345
phone interventions for improving PA levels in patients with
COPD.
Conclusions
The effectiveness of smartphone devices in promoting PA and
exercise in patients with COPD is yet too soon to be shown. 350
Future studies of high quality are needed to evaluate the effec-
tiveness of these devices in the promotion of PA and physical
exercise before its clinical recommendation.
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